Pancreatic Cancer

Protein linked to prognosis of cancer patients

Published in Cancer Weekly, May 10th, 2005

Cancer Research U.K. scientists at the University of Liverpool have made a surprise discovery that could predict which pancreatic cancer patients are likely to do better after surgery, a new paper reveals.

The study shows that pancreatic cancer patients have better prospects when levels of a specific protein are low or undetectable in the cell nucleus. It was published in Cancer Research.

The protein at the center of the discovery is called calcyclin. Its role in pancreatic cancer is unknown, but researchers believe that patients who do not produce this protein have a better outcome.

The research was carried out on pancreas...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-05-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry